Showing results (261-270 of 332) with videos related to
Sort By:
Pageof 34
European Journal of Immunology|June 1, 1993
Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytesH W Nijman, J G Houbiers, M P Vierboom, et al.Traffic (Copenhagen, Denmark)|March 15, 2001
Antigen loading of MHC class I molecules in the endocytic tractM J Kleijmeer, J M Escola, F G UytdeHaag, et al.European Journal of Immunology|May 6, 1999
Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinomaM E Ressing, J H de Jong, R M Brandt, et al.European Journal of Immunology|June 1, 1992
Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activationE Van de Wiel-van Kemenade, A A Te Velde, A J De Boer, et al.Proceedings of the National Academy of Sciences of the United States of America|December 10, 1996
Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptideM Röpke, J Hald, P Guldberg, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage siteN J Beekman, P A van Veelen, T van Hall, et al.Journal of Virology|September 1, 1994
Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 miceA J Sijts, M L De Bruijn, M E Ressing, et al.Nature Medicine|December 1, 1995
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunityJ I Mayordomo, T Zorina, W J Storkus, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Longevity of antigen presentation and activation status of APC are decisive factors in the balance between CTL immunity versus toleranceA T den Boer, L Diehl, G J van Mierlo, et al.European Journal of Immunology|September 1, 1993
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cellsM C Feltkamp, H L Smits, M P Vierboom, et al.Pageof 34